|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1997-8-5
|
|
pubmed:abstractText |
To determine if maternal serum levels of human placental lactogen (hPL), estradiol, and pregnancy-specific beta 1-glycoprotein (SP1) measured at approximately 18 weeks' gestation were associated with fetal growth retardation (FGR) in infants delivered at or after 37 weeks.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-8835
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
165
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
56-8
|
|
pubmed:dateRevised |
2008-2-21
|
|
pubmed:meshHeading |
pubmed-meshheading:9219458-Alabama,
pubmed-meshheading:9219458-Estradiol,
pubmed-meshheading:9219458-Female,
pubmed-meshheading:9219458-Fetal Growth Retardation,
pubmed-meshheading:9219458-Gestational Age,
pubmed-meshheading:9219458-Humans,
pubmed-meshheading:9219458-Incidence,
pubmed-meshheading:9219458-Infant, Newborn,
pubmed-meshheading:9219458-Infant, Small for Gestational Age,
pubmed-meshheading:9219458-Placental Lactogen,
pubmed-meshheading:9219458-Predictive Value of Tests,
pubmed-meshheading:9219458-Pregnancy,
pubmed-meshheading:9219458-Pregnancy-Specific beta 1-Glycoproteins,
pubmed-meshheading:9219458-Prevalence,
pubmed-meshheading:9219458-Risk Factors
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Maternal serum concentrations of human placental lactogen, estradiol and pregnancy specific beta 1-glycoprotein and fetal growth retardation.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University of Alabama at Birmingham, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
